eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Molnlycke Health Care

Two Omega Drive, Irlam, Manchester, M44 5BJ , UK
Telephone: +44 (0)161 777 2600
Fax: +44 (0)161 777 2601
WWW: http://www.molnlycke.com
Medical Information Direct Line: +44 (0)161 777 2628
Medical Information e-mail: ukmedical.information@molnlycke.com
Customer Care direct line: +44 (0)161 777 2600
Medical Information Fax: +44 (0)161 621 2045

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 20/09/2006
SPC Betadine Skin Cleanser


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Betadine Skin Cleanser.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Povidone Iodine USP 4.00% w/v.


Go to top of the page
3. PHARMACEUTICAL FORM

Topical aqueous solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Acne vulgaris of the face and neck. For general disinfection of the skin (as a liquid soap).


Go to top of the page
4.2 Posology and method of administration

Route of administration: Topical. Adults, the elderly and children over 2 years: Apply directly or with moistened sponge to the affected areas and work up a rich lather. Allow to remain on the skin for 3-5 minutes then rinse off thoroughly with warm water and dry with a clean or sterile towel or gauze. Repeat twice daily. Infants under 2 years: Limit use to 2-3 days.


Go to top of the page
4.3 Contraindications

Hypersensitivity to iodine. History of abnormal thyroid function or goitre.


Go to top of the page
4.4 Special warnings and precautions for use

Do not use on broken skin. Iodine is absorbed through burns and broken skin and, to a lesser extent, through intact skin. Restrict use in infants to 2-3 days.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Use in pregnancy and lactation should be limited and although no adverse effects are anticipated from such limited usage, caution is recommended and the therapeutic benefit must be balanced against the possible effects of the absorption of iodine on foetal thyroid function.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

If local irritation or sensitivity develops, then discontinue treatment.


Go to top of the page
4.9 Overdose

Treatment: In the case of deliberate or accidental ingestion of large quantities of Betadine, symptomatic and supportive treatment should be provided with special attention to electrolyte balance and renal and thyroid function.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Betadine Skin Cleanser contains povidone iodine, a complex of iodine which shows all the broad-spectrum germicidal activity of elemental iodine. The germicidal activity is maintained in the presence of exfoliative debris and infected lesions whilst the colour persists. Betadine Skin Cleanser kills bacteria, viruses, fungi, spores and protozoa.


Go to top of the page
5.2 Pharmacokinetic properties

The product is intended for topical application.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Purified water; potassium iodate; NPPE ester; lauric diethanolamide; Natrosol HXR; Vah Floral Perfume No 2; sodium hydroxide.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

36 months


Go to top of the page
6.4 Special precautions for storage

Store at a temperature not exceeding 25oC.


Go to top of the page
6.5 Nature and contents of container

Polypropylene container with polypropylene lid containing 250ml.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Medlock Medical Limited, Tubiton House, Medlock Street, Oldham, OL1 3HS.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 21248/0015.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

30th March 2005.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

May 2006.



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1957/SPC/


Active Ingredients/Generics

 
   povidone iodine